AND	term1 AND term2	Both terms must be included
OR	term1 OR term2	Either term
NOT	term1 NOT term2	term2 must not appear
""	"term1 term2"	Exact match
()	term1 AND (term2 OR term3)	Grouping terms
?	withdr?w	Single letter wildcard (withdraw, withdrew)
*	withdr*	Multiple letter wildcard (withdraw, withdrawn, withdrawing)
"..."~n	"term1 term2"~n	Proximity (term1 within n words of term2)

Search results

Order by: most recent most popular relevance

Jurisdiction

Work area

Firm name

Date from

Date to

Results:1-10 of 466

Justice Department Allots Additional US$70 Million to Battle Opioid Crisis

Squire Patton Boggs
USA
November 7 2018

In tandem with President Trump’s signing of H.R. 6, (now former) US Attorney General Jeff Sessions announced new Department of Justice (DOJ) funding

The SUPPORT for Patients and Communities Act: Expanding Medicare Coverage of Telehealth Services to Combat the Opioid Crisis

Epstein Becker Green
USA
November 5 2018

The SUPPORT for Patients and Communities Act (“the Act” or “the SUPPORT Act”), signed into law by President Trump on October 24, 2018, is intended to

The U.S. Department of Health and Human Services Launches New Opioid-Related Initiatives

Dykema Gossett PLLC
USA
November 2 2018

Following President Trump’s signature on broad federal legislation to combat the opioid crisis in the U.S., the U.S. Department of Health and Human

Federal government takes steps toward ubiquity of cannabis drugs

Reed Smith LLP
USA
November 1 2018

The federal government finally seems ready to acknowledge the potential advantages of medicinal CBD and marijuana-derived medication. The Food and

How SUPPORT Will Affect Pharma Interactions With DEA

Cadwalader Wickersham & Taft LLP
USA
October 31 2018

The opioid package President Donald Trump signed last week garnered much attention. While it is largely directed at treatment and prevention, it

The Feds and New York Allow Further Access to CBD and Medical Cannabis

Wilson Elser
USA
October 24 2018

On September 28, 2018, the Drug Enforcement Administration (DEA) took the long-awaited step of rescheduling Epidiolex - the first FDA-approved drug

DEA to Propose Significant Regulatory Changes in the Coming Year

Quarles & Brady LLP
USA
October 23 2018

The Department of Justice recently published its list of proposed regulatory actions for the near and long term. It appears that the Drug Enforcement

6th Circ. Ruling Highlights Dangers Of Insured's Admissions

Jenner & Block LLP
USA
October 17 2018

The Sixth Circuit’s recent decision in K.V.G. Properties, Inc. v. Westfield Insurance Co.underscores that an insured’s admissions in non-insurance

The DEA Affirms CBD Derived from “Marijuana” Is Federally Unlawful

Duane Morris LLP
USA
October 12 2018

The Controlled Substances Act defines “marijuana” as: all parts of the plant Cannabis sativa L., whether growing or not; the seeds thereof; the resin

The Long-Awaited Telemedicine Controlled Substance Prescribing Permit

Bryan Cave Leighton Paisner LLP
USA
October 11 2018

Last week, the United States Congress passed a 250-page bill addressing the opioid crisis entitled SUPPORT for Patients and Communities Act (the

Search techniques

Current Search

Refine

Content type

Tags